跳至主要内容
临床试验/JPRN-UMIN000016273
JPRN-UMIN000016273已完成未知

Rheumatoid Arthritis with Orencia Trial Toward Sjogren's syndrome Endocrinopathy (ROSE II Trial) - Rheumatoid Arthritis with Orencia Trial Toward Sjogren's syndrome syndrome Endocrinopathy (ROSE II Trial)

Department of Internal Medicine, Faculty of Medicine, University of Tsukuba0 个研究点目标入组 68 人开始时间: 2015年1月20日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with contraindication for abatacept 2) Aged 75 and more than 75 years old 3) Patients with leukopenia (leukocyte count<=3000) and positive for B-D Glucan 4) Patients who are pregnant, nursing, want to get pregnant 5) Aged less than 20 years old 6) Patients who are treated with palliative therapies for dryness including cevimeline, anetholtritione, and pilocarpine within the last 4 weeks 7) Patients with severe liver or kidney diseases, severe hematological disorders 8) Patients with negative for both anti-SS-A and SS-B antibody and positive for anti-centromere antibody 9) Patients who are considered not suitable for this study by the attending physicians

研究者

发起方
Department of Internal Medicine, Faculty of Medicine, University of Tsukuba

相似试验